Correlation Between Visa and Kobayashi Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Visa and Kobayashi Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Kobayashi Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Kobayashi Pharmaceutical Co, you can compare the effects of market volatilities on Visa and Kobayashi Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Kobayashi Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Kobayashi Pharmaceutical.
Diversification Opportunities for Visa and Kobayashi Pharmaceutical
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Visa and Kobayashi is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Kobayashi Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kobayashi Pharmaceutical and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Kobayashi Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kobayashi Pharmaceutical has no effect on the direction of Visa i.e., Visa and Kobayashi Pharmaceutical go up and down completely randomly.
Pair Corralation between Visa and Kobayashi Pharmaceutical
If you would invest 27,343 in Visa Class A on September 3, 2024 and sell it today you would earn a total of 4,165 from holding Visa Class A or generate 15.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 12.8% |
Values | Daily Returns |
Visa Class A vs. Kobayashi Pharmaceutical Co
Performance |
Timeline |
Visa Class A |
Kobayashi Pharmaceutical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Visa and Kobayashi Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Visa and Kobayashi Pharmaceutical
The main advantage of trading using opposite Visa and Kobayashi Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Kobayashi Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kobayashi Pharmaceutical will offset losses from the drop in Kobayashi Pharmaceutical's long position.Visa vs. American Express | Visa vs. Capital One Financial | Visa vs. Upstart Holdings | Visa vs. Ally Financial |
Kobayashi Pharmaceutical vs. Constellation Brands Class | Kobayashi Pharmaceutical vs. Trupanion | Kobayashi Pharmaceutical vs. Kinsale Capital Group | Kobayashi Pharmaceutical vs. The Hanover Insurance |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |